BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Rankinidine | Rankinidine is found in Gelsmium elegans. Group: Pharmaceutical. CAS No. 106466-66-4. Pack Sizes: 5 mg. Product ID: B2703-334734. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Ranolazine Impurities | Ranolazine Impurities, integral to pharmaceutical inquiry, aid in validating Ranolazine's safety and effectivenessa key therapeutic for chronic angina. Through meticulous analysis of these impurities, researchers refine drug formulations, enhancing therapeutic efficacy and advancing cardiovascular disease management. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rapamycin | Rapamycin is an mTOR inhibitor immunosuppressant and kinase inhibitor with both antifungal and antineoplastic properties. It selectively inhibits the transcriptional activation of cytokines. Uses: Antifungal and antineoplastic agent. Group: Pharmaceutical. CAS No. 53123-88-9. Pack Sizes: 500 mg. Product ID: BBF-02627. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rapamycin Impurities | Rapamycin Impurities, quintessential in the pharmaceutical sector, function as pivotal indicators of drug purity and stability. Essential for confirming the efficacy and safety of Rapamycin, a critical mTOR pathway inhibitor, their role spans organ transplant rejection prevention and oncological applications, thus serving as sentinels in therapeutic precision. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rapanone | Rapanone is found in Embelia laeta. Group: Pharmaceutical. CAS No. 573-40-0. Pack Sizes: 10 mg. Product ID: B2703-028160. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rapastinel | Rapastinel, a brain penetrable tetrapeptide, could be a partial agonist of NMDA receptor. It was already finished the Phase II trial for acting as an antidepressant agent. It was just planed a phase III trial for Major depressive disorder. Uses: Rapastinel is a brain penetrable tetrapeptide and could be a partial agonist of nmda receptor. Group: Pharmaceutical. CAS No. 117928-94-6. Pack Sizes: 5 mg. Product ID: BAT-010744. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rasagiline Impurities | Rasagiline Impurities, integral to pharmaceutical quality assurance, are pivotal in the drug development lifecycle for Parkinson's treatment. Through comprehensive analysis of these impurities, insights into the medication's stability, efficacy, and safety are gleaned, ensuring adherence to rigorous pharmaceutical standards and safeguarding therapeutic reliability. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rasagiline mesylate | Rasagiline (N-propargyl-1-(R)-aminoindan) is a novel, highly potent irreversible monoamine oxidase (MAO)-B inhibitor, anti-Parkinsonian drug. Uses: Neuroprotective agents. Group: Pharmaceutical. CAS No. 161735-79-1. Pack Sizes: 500 mg. Product ID: NP3667. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Raubasine Impurities | Raubasine Impurities hold significant importance in pharmaceutical realms, serving a critical function in the meticulous quality control of raubasine-centric medications aimed at cerebrovascular ailment management. These entities facilitate the precise delineation and quantification of active constituents and remnants, thus safeguarding the safety and efficacy of therapeutic formulations. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rauvotetraphylline B | Rauvotetraphylline B is an alkaloid isolated from Rauvotetraphyllum. Group: Pharmaceutical. CAS No. 1422506-50-0. Pack Sizes: 1 mg. Product ID: NP0158. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rauvovertine A | Rauvovertine A is an alkaloid isolated from the stems of Rauvolfia verticillata and exhibits anti-tumor activity. Group: Pharmaceutical. CAS No. 2055073-75-9. Pack Sizes: 1 mg. Product ID: NP0666. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Raxatrigine | Raxatrigine is a novel analgesic for the treatment of lumbosacral radiculopathy (sciatica) and trigeminal neuralgia. It acts as a selective, small-molecule, state-dependent Nav1.7 voltage-gated sodium channel blocker. It is a peripherally and centrally acting agent that inhibits sodium channels in a state-dependent fashion. It shows selectivity for the Nav1.7 subtype over the other subtypes tested for both the resting and depolarized states. It was developed by Convergence Pharmaceuticals. It received orphan-drug designation from the US Food and Drug Administration in July 2013. It is currently in phase II studies in bipolar depression. Uses: Raxatrigine is a novel analgesic for the treatment of lumbosacral radiculopathy (sciatica) and trigeminal neuralgia. it received orphan-drug designation from the us food and drug administration in july 2013. Group: Pharmaceutical. CAS No. 934240-30-9. Pack Sizes: 25 mg. Product ID: B0084-474126. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Raxatrigine Impurities | Raxatrigine Impurities, essential in pharmaco-analytical rigor, underpin the evolutionary architecture of Raxatrigine, a critical neuropathic and epileptic intervention. Their exhaustive chemical characterization secures drug safety and efficacy, thus propelling formulation enhancement and honing therapeutic exactitude, representing a cornerstone in medicinal developmental strategy. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (R)-Baclofen | (R)-Baclofen is the R-enantiomer of Baclofen, which is a specific GABA-B receptor agonist and muscle relaxant (skeletal). It is primarily used to treat spasticity. Group: Pharmaceutical. CAS No. 69308-37-8. Pack Sizes: 5 g. Product ID: B0084-097120. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| RBC8 | RBC8 is a novel small molecule inhibitor of Ral GTPase; has IC50 of 3.5 μM in H2122 cell and 3.4 μM in H358 cell. Group: Pharmaceutical. CAS No. 361185-42-4. Pack Sizes: 50 mg. Product ID: B0084-463350. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| RC 160 | RC 160 is a cyclic octapeptide somatostatin analog (Ki= 0.7, 5.4, 30.9, 45 and > 1000 nM for sst5, sst2, sst3, sst4 and sst1 receptors respectively). RC 160 is a peptide neurokinin-1 receptor (NK1) antagonist and inhibits increases in vascular permeability stimulated by substance P in a concentration-dependent manner in isolated guinea pig trachea and main bronchi. It is used in the treatment of esophageal variceal bleeding in patients with cirrhotic liver disease and AIDS-related diarrhea. Uses: Antineoplastic agents. Group: Pharmaceutical. CAS No. 103222-11-3. Pack Sizes: 5 mg. Product ID: BAT-006135. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (R)-Cetirizine-[d4] Dihydrochloride | (R)-Cetirizine-[d4] Dihydrochloride is the labelled salt of Levocetirizine, which is a histamine H1 receptor antagonist and could be used as an antihystaminic agent. Group: Pharmaceutical. Pack Sizes: 1 mg. Product ID: BLP-004494. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (R)-Citalopram Oxalate | (R)-Citalopram Oxalate is an inhibitor of serotonin (5-HT) uptake. It shows antidepressant activity. Group: Pharmaceutical. CAS No. 219861-53-7. Pack Sizes: 25 mg. Product ID: B0211-469040. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (R)-Coclaurine | (R)-Coclaurine is a nicotinic acetylcholine receptor antagonist isolated from a variety of plant sources. Group: Pharmaceutical. CAS No. 2196-60-3. Pack Sizes: 5 mg. Product ID: B2703-279867. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rebamipide | Rebamipide has been shown to enhance mucosal defense by scavenging free radicals, and temporarily activating genes encoding cyclooxygenase-2. Uses: Enzyme inhibitors. Group: Pharmaceutical. CAS No. 90098-04-7. Pack Sizes: 20 g. Product ID: B0084-100251. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rebamipide Impurities | Rebamipide Impurities are analyzed in the biomedical field to ensure the purity and efficacy of Rebamipide, which is widely used to treat gastric ulcers and mucosal inflammation. Understanding these impurities contributes to the development and safety evaluation of gastrointestinal drugs aimed at improving mucosal health. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rebamipide impurity 2 | An impurity of Rebamipide. Rebamipide is an amino acid derivative of 2-(1H)-quinolinone. It can be used for mucosal protection, healing of gastroduodenal ulcers, and treatment of gastritis. Group: Pharmaceutical. CAS No. 94670-39-0. Pack Sizes: 50 mg. Product ID: B2694-483699. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rebastinib | Rebastinib is an orally bioactive inhibitor of Bcr-Abl that binds to and inhibits Bcr-Abl fusion oncoprotein. Rebastinib changes the conformation of the folded protein to disallow ligand-dependent and ligand-independent activation. It also exhibits inhibitory activity at SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2. Uses: Antineoplastic agents. Group: Pharmaceutical. CAS No. 1020172-07-9. Pack Sizes: 50 mg. Product ID: B0084-307739. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rebaudioside A | Rebaudioside A is extracted from the leaves of Stevia rebaudiana Bertoni. It is a glucosylated steviol glycoside studied and used as a non-glycemic food sweetener. It is approximately 250 to 300 times sweeter than sucrose. It does not contribute calories or carbohydrates to the diet and do not affect blood glucose or insulin response. It is safe for human consumption under its intended conditions of use as a general purpose sweetener. Group: Pharmaceutical. CAS No. 58543-16-1. Pack Sizes: 50 g. Product ID: NP1551. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rebaudioside D | Rebaudioside D is extracted from the leaves of Stevia rebaudiana Bertoni. It is a potential sweetener. It showed similar stability when exposed to simulated stomach and small intestine fluids, with susceptibility to hydrolytic degradation by enteric bacteria collected from the cecum. Group: Pharmaceutical. CAS No. 63279-13-0. Pack Sizes: 10 mg. Product ID: B2703-003552. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rebaudioside I | Rebaudioside I, a plant-derived non-caloric sweetener extracted from Stevia rebaudiana leaves, has been widely adopted in food and beverage industries as a sugar supplement. Beyond its sweetness, this compound demonstrates tremendous potential for managing type 2 diabetes, by enhancing insulin secretion and improving glucose tolerance. Evidence also suggests that rebaudioside I may possess both anti-inflammatory and anti-tumor properties, making it a promising candidate for therapeutic applications. Group: Pharmaceutical. CAS No. 1220616-34-1. Pack Sizes: 1 mg. Product ID: B1999-003557. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rebaudioside M | Rebaudioside M is a natural sweetener extracted from the stevia plant. It is commonly used as a substitute for sugar in various food and beverage products due to its high sweetness and low calorie content. Additionally, studies have shown that rebaudioside M may have potential applications in the treatment of diabetes and obesity due to its ability to regulate blood sugar levels and improve insulin sensitivity. Group: Pharmaceutical. CAS No. 1220616-44-3. Pack Sizes: 10 mg. Product ID: B2705-003561. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rebeprazole sulfone N-oxide | An impurity of Rabeprazole. Rabeprazole is a proton pump inhibitor as an antiulcer drug. Group: Pharmaceutical. CAS No. 924663-37-6. Pack Sizes: 50 mg. Product ID: B2694-100630. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Reboxetine Impurities | Reboxetine Impurities are crucial reference materials in the pharmaceutical industry for ensuring quality control during the manufacture of reboxetine, an antidepressant primarily used to treat major depressive disorder. Studying these impurities aids in understanding the drug's stability and purity and ensures therapeutic efficacy and safety. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Reboxetine Mesylate | Reboxetine is a norepinephrine reuptake inhibitor with Ki of 8.2 nM. Group: Pharmaceutical. CAS No. 98769-84-7. Pack Sizes: 500 mg. Product ID: B2694-158042. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Recombinant IGF-I (human) | Recombinant IGF-I (human) is a monoclonal antibody that binds to the epidermal growth factor receptor (EGFR) and inhibits its activity. Group: Pharmaceutical. CAS No. 67763-96-6. Pack Sizes: 1 mg. Product ID: BAT-010854. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rediocide A | Rediocide A is extracted from the herbs of Trigonostemon reidioides (Kurz) Craib. It can inhibit calcium mobilization in Drosophila G-protein- coupled receptors (GPCR)s other than methuselah and induce GPCR internalization and desensitization, which are mediated by the activation of conventional protein kinase C. It displays potent activity against fleas (Ctenocephalides felis) in an artificial membrane feeding system with LD(90) values ranging from 0.25 to 0.5 ppm. It is used as an insecticide. Group: Pharmaceutical. CAS No. 280565-85-7. Pack Sizes: 1 mg. Product ID: NP1570. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rediocide C | Rediocide C is extracted from the herbs of Trigonostemon reidioides (Kurz) Craib. It has antimycobacterial activity with the MIC value of 3.84 uM. It also shows potent activity against D. pteronyssinus with LC50 value of 5.59 microg/cm2. Group: Pharmaceutical. CAS No. 677277-98-4. Pack Sizes: 1 mg. Product ID: NP1609. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Regadenoson | Regadenoson, as a coronary vasodilator it is a selective A2A adenosine receptor agonist in myocardial imaging. Uses: A selective a2a adenosine receptor agonist in myocardial imaging. Group: Pharmaceutical. CAS No. 313348-27-5. Pack Sizes: 25 mg. Product ID: B0084-107114. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Regorafenib | Regorafenib, also known as BAY 73-4506, is an orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities. Regorafenib binds to and inhibits vascular endothelial growth factor receptors (VEGFRs) 2 and 3, and Ret, Kit, PDGFR and Raf kinases, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation. VEGFRs are receptor tyrosine kinases that play important roles in tumor angiogenesis; the receptor tyrosine kinases RET, KIT, and PDGFR, and the serine/threonine-specific Raf kinase are involved in tumor cell signaling. Regorafenib is demonstrated to increase the overall survival of patients with metastatic colorectal cancer and has been approved by the US FDA on September 27, 2012. Uses: Antineoplastic agent. Group: Pharmaceutical. CAS No. 755037-03-7. Pack Sizes: 500 mg. Product ID: BBF-05856. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Regorafenib Hydrochloride | Regorafenib Hydrochloride is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit, RET and Raf-1. Group: Pharmaceutical. CAS No. 835621-07-3. Pack Sizes: 25 mg. Product ID: B2693-459775. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Regorafenib Impurities | Regorafenib impurities are essential analytical components in assuring the quality control of regorafenib, a multi-kinase inhibitor utilized in colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma treatments. Their detection safeguards pharmaceutical integrity and therapeutic efficacy, targeting crucial pathways implicated in tumor proliferation and angiogenesis. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Regorafenib Impurity 6 | An impurity of Regorafenib.Regorafenib is a multi-kinase inhibitor which targets angiogenic, stromal and oncogenic receptor tyrosine kinase. It shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition. Group: Pharmaceutical. CAS No. 1187945-05-6. Pack Sizes: 50 mg. Product ID: B2694-483711. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Regorafenib monohydrate | Regorafenib monohydrate is a multitargetedinhibitor of tyrosine kinase with IC50 values of 13nM, 4.2nM, 46nM, 2.5nM, 28nM, 19nM, 202nM, 22nM, 7nM, 1.5nM and 311nM, respectively for VEGFR-1, mVEGFR-2, mVEGFR-3, Raf-1, BRAF WT, BRAFV600E, FGFR-1, PDGFR-β, c-KIT, RET and TIE2. Group: Pharmaceutical. CAS No. 1019206-88-2. Pack Sizes: 250 mg. Product ID: B2693-463493. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Regorafenib N-Oxide (M2 Metabolite) | A metabolite of Regorafenib. Regorafenib is a multi-kinase inhibitor which targets angiogenic, stromal and oncogenic receptor tyrosine kinase. It shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition. Group: Pharmaceutical. CAS No. 835621-11-9. Pack Sizes: 25 mg. Product ID: B2694-483714. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rehmannic acid | Rehmannic acid is a natural triterpenoid found in the herbs of Lantana camara. Rehmannic acid has inhibit succinoxidase activity. Group: Pharmaceutical. CAS No. 467-81-2. Pack Sizes: 1 mg. Product ID: NP6783. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Relacorilant | Relacorilant is an antagonist of glucocorticoid receptor which is under development for the treatment of Cushing's syndrome. Group: Pharmaceutical. CAS No. 1496510-51-0. Pack Sizes: 5 mg. Product ID: B2693-346651. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Relamorelin | Relamorelin is a synthetic, centrally penetrant, selective agonist of the ghrelin/growth hormone secretagogue receptor (GHSR). It is potentially useful for the treatment of diabetic gastroparesis, chronic idiopathic constipation, and anorexia nervosa. It is a pentapeptide and an analogue of ghrelin. It produces increases in plasma growth hormone, prolactin, and cortisol levels, and increases appetite in humans. It is under development by Rhythm Pharmaceuticals and is in phase II clinical trials. Uses: Relamorelin is potentially useful for the treatment of diabetic gastroparesis, chronic idiopathic constipation, and anorexia nervosa. Group: Pharmaceutical. CAS No. 661472-41-9. Pack Sizes: 10 mg. Product ID: B2693-476090. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Relcovaptan Impurities | Relcovaptan Impurities are critical in the biomedical industry for assessing the purity and efficacy of Relcovaptan, a vasopressin V1a receptor antagonist. They aid in quality control and safety evaluation, ensuring therapeutic potency, especially in treating Raynaud's disease and dysmenorrhea, conditions linked to vascular dysfunction. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Relebactam | Relebactam, a diazabicyclooctane derivative, has a broad spectrum inhibitory activity against β-lactamases. It has been studied to be probably effective in the treatment of Gram-negative bacterial infections combinated with Primaxin. Uses: Beta-lactamase inhibitors. Group: Pharmaceutical. CAS No. 1174018-99-5. Pack Sizes: 100 mg. Product ID: B2693-474368. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Relugolix | Relugolix, also known as TAK-385, is a luteinizing hormone-releasing hormone (LH-RH) receptor antagonist administered orally. By preventing LH-RH from binding with the LH-RH receptor in the anterior pituitary gland and suppressing the secretion of luteinizing hormone (LH) and follicle stimulation hormone (FSH) from the anterior pituitary gland, TAK-385 controls the effect of LH and FSH on the ovary, reduces the level of estrogen in blood, which is known to be associated with the development of endometriosis and uterine fibroids, and is expected to improve the symptoms of these disorders. Uses: Androgen antagonists. Group: Pharmaceutical. CAS No. 737789-87-6. Pack Sizes: 10 mg. Product ID: B0084-462794. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Remdesivir | Remdesivir, an analog nucleotide inhibitor, with effectively antiviral activity in vitro against various virus, including Ebola virus, Marburg virus, HCoV-NL63, HCoV-OC43, HCoV-229E, Mouse hepatitis virus (MHV), SARS-CoV, MERS-CoV and related bat coronavirus, HKU5, and PDCoV (porcine delta-coronavirus). Remdesivir is also reported to have potential antiviral activity against a 2019 novel coronavirus (called 2019-nCoV, nCoV2019 or COVID-19). Group: Pharmaceutical. CAS No. 1809249-37-3. Pack Sizes: 200 mg. Product ID: B2692-291708. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Remdesivir Impurities | Remdesivir Impurities constitute essential analytical standards within the biomedical domain, crucial for the stringent oversight of remdesivir synthesis validation and quality control. Their role is instrumental in affirming the therapeutic efficacy and safety of remdesivir, a predominant antiviral agent administered in COVID-19 treatment protocols. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Remifentanil Impurities | Remifentanil Impurities, central to biomedical inquiry, enable intricate analysis of remifentanil's synthetic pathways and pharmacokinetic attributes. Examining these impurities is crucial for ensuring the purity, safety, and efficacy of this opioid analgesic, fundamental for alleviating acute pain and refining anesthetic methodologies, ultimately securing optimal therapeutic efficacy. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Remodelin hydrobromide | Remodelin, via inhibition of NAT10, mediates nuclear shape rescue of LMNA depleted cells by microtubule reorganization, and improves nuclear shape and fitness of HGPS cells. Group: Pharmaceutical. CAS No. 1622921-15-6. Pack Sizes: 50 mg. Product ID: B0084-463446. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Remogliflozin etabonate | Remogliflozin etabonat, pro-drug of remogliflozin, is a SGLT2 inhibitor under development for the treatment of type 2 diabetes. Remogliflozin etabonate is a pro-drug of remogliflozin, inhibits the sodium-glucose transport proteins (SGLT), which are responsible for glucose reabsorption in the kidney. Uses: Sglt2 inhibitor. Group: Pharmaceutical. CAS No. 442201-24-3. Pack Sizes: 5 mg. Product ID: B2693-459192. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Renzapride | Renzapride is a full 5-HT4 agonist and partial 5-HT3 antagonist. Renzapride has been used for the treatment of constipation-predominant irritable bowel syndrome (IBS-C). Uses: Serotonin antagonists. Group: Pharmaceutical. CAS No. 112727-80-7. Pack Sizes: 25 mg. Product ID: B1370-160931. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Renzapride hydrochloride | Renzapride is a gastroprokinetic agent and antiemetic which acts as a 5-HT4 full agonist and 5-HT3 antagonist. Group: Pharmaceutical. CAS No. 109872-41-5. Pack Sizes: 100 mg. Product ID: B2692-469682. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Repaglinide | Repaglinide is a potassium channel blocker, which lowers blood glucose by stimulating the release of insulin from the pancreas, used for the treatment of type II diabetes. Group: Pharmaceutical. CAS No. 135062-02-1. Pack Sizes: 1 g. Product ID: NP3248. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Repaglinide Impurities | Repaglinide Impurities are crucial in the biomedical industry for quality control and the development of antidiabetic medications. These impurities are analyzed to ensure the purity and efficacy of Repaglinide, a drug used to manage type 2 diabetes by stimulating insulin release from the pancreas. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Repaglinide Impurity E | An impurity of Repaglinide, an antidiabetic drug. Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus. Uses: Hypoglycemic agents. Group: Pharmaceutical. CAS No. 147852-26-4. Pack Sizes: 1 g. Product ID: B1370-263819. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Repirinast Impurities | Repirinast Impurities are critical in the biomedical industry for assessing Repirinast's purity and safety, primarily as an anti-allergic drug. These impurities are essential in quality control and regulatory submissions, ensuring the therapeutic efficacy and safety profile of pharmaceuticals used to treat asthma and chronic allergic rhinitis. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Repotrectinib | TPX-0005 is an orally available and potent ATP-competitive inhibitor of ALK/ROS1/TRK (IC50= 5.3 nM for SRC, IC50= 1.01 nM, 1.26 nM and 1.08 nM for mutant ALKs including WT ALK, ALK G1202R and ALK L1196M, respectively). Group: Pharmaceutical. CAS No. 1802220-02-5. Pack Sizes: 25 mg. Product ID: B2693-007261. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Resatorvid Impurities | Resatorvid Impurities occupy a critical niche in pharmacological research, significantly impacting the development and quality assurance of Resatorvid, especially in combating septic shock and inflammatory conditions. Essential for assessing therapeutic efficacy and safety, they facilitate meticulous drug purity analysis, thereby refining therapeutic formulation methodologies. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Resiniferatoxin Impurities | Resiniferatoxin Impurities are studied in biomedical research to understand their effects on receptor activity modulation, specifically in treating pain conditions. They provide insights into developing new analgesics targeting nerve-related disorders. Furthermore, these impurities help elucidate structure-activity relationships crucial for advancing neuropharmacological therapies. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Resiquimod | Resiquimod is an imidazoquinolinamine and TLR7 agonist with antitumor and antiviral activity. Uses: Resiquimod may be used in immunological and cancer-related cell signaling studies. Group: Pharmaceutical. CAS No. 144875-48-9. Pack Sizes: 250 mg. Product ID: B0084-058890. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Resiquimod-[d5] | Resiquimod-[d5] is an isotope labelled Resiquimod, an imidazoquinolinamine and Toll-like receptor (TLR) agonist. Group: Pharmaceutical. CAS No. 2252319-44-9. Pack Sizes: 10 mg. Product ID: BLP-009581. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Resiquimod Impurities | Resiquimod impurities are critical constituents in biomedical analysis, facilitating the assurance of Resiquimod's puritya formidable immune response modifier. Employed in treating dermatological ailments and certain viral infections like actinic keratosis and cutaneous T-cell lymphoma, impurity profiling is vital for maintaining drug safety and therapeutic efficacy. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Resorufin | Resazurin is a blue dye, itself weakly fluorescent until it is irreversibly reduced to the pink colored and highly red fluorescent resorufin. It can be used as an oxidation-reduction indicator in cell viability assays for both aerobic and anaerobic respiration. Group: Pharmaceutical. CAS No. 635-78-9. Pack Sizes: 1 g. Product ID: B2708-130394. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Resorufin Impurities | Resorufin Impurities are critical intermediates in drug metabolism studies and diagnostics. They are primarily utilized to investigate enzymatic activity in various cancers and liver diseases, offering potential insights for creating highly effective therapeutic agents. Additionally, their role extends to oxidative stress research, contributing to the understanding of diverse pathologies. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Resveratrol | Resveratrol is a phytoalexin derived from grapes and other food products with antioxidant and potential chemopreventive activities. Resveratrol induces phase II drug-metabolizing enzymes (anti-initiation activity), mediates anti-inflammatory effects and inhibits cyclooxygenase and hydroperoxidase functions (anti-promotion activity), and induces promyelocytic leukemia cell differentiation (anti-progression activity), thereby exhibiting activities in three major steps of carcinogenesis. This agent may inhibit TNF-induced activation of NF-kappaB in a dose-and time-dependent manner. Resveratrol is a natural compound used in cosmetic materials. It is widely used in anti-aging and wrinkle removal, whitening and whitening spots, antibacterial and anti-inflammatory, oil control and acne, anti-allergy and analgesia, scar repair, hair care and other products, and it is compatible with lotion cream formula, gel formula and water formula. Uses: Ingredient of health care products. Group: Pharmaceutical. CAS No. 501-36-0. Pack Sizes: 20 g. Product ID: BBF-03781. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Resveratrol Impurities | Resveratrol Impurities, essential in the realm of biomedical investigation, facilitate the refinement and progress of resveratrol-derived medical interventions. By allowing in-depth pharmacokinetic and pharmacodynamic evaluations, they amplify the therapeutic potential of resveratrol, particularly in addressing cardiovascular maladies, diabetes, and specific oncological challenges, thereby refining efficacy and bolstering safety protocols. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Retapamulin | Retapamulin (SB-275833) is a topical antibiotic, which binds to both E. coli and S. aureus ribosomes with similar potencies with Kd of 3 nM. Uses: For research use only. Group: Pharmaceutical. CAS No. 224452-66-8. Pack Sizes: 1 g. Product ID: BBF-03853. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Retapamulin Impurities | Retapamulin Impurities are pivotal in the pharmaceutical industry for quality control and structural analysis during the manufacturing of retapamulin, an antibiotic used to treat skin infections like impetigo. These impurities aid researchers in ensuring the purity, efficacy, and safety of the final retapamulin product. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Retatrutide | Retatrutide is a triple glucagon, GIP, and GLP-1 receptor agonist. Retatrutide showed glucose control and weight loss in patients with type 2 diabetes mellitus (T2DM). Uses: retatrutide is a new peptide medication that has showed great promise in drug discovery because of its distinct mode of action and its medicinal uses. the high specificity and affinity of retitrutide for its target receptors is one of the main characteristics that make it an attractive option for drug discovery. this peptide is engineered to bind specifically to specific cell surface receptors. Group: Pharmaceutical. CAS No. 2381089-83-2. Pack Sizes: 10 mg. Product ID: BAT-016112. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.